Results 251 to 260 of about 171,004 (312)

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer   +4 more
wiley   +1 more source

Safety concerns reported by coroners following fentanyl patch fatalities in England, Wales and Northern Ireland between 1997 and 2024

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim To identify safety concerns reported by coroners following fentanyl patch‐related deaths in England, Wales and Northern Ireland, and determine differences in coronial reporting. Methods A systematic case series linking the National Programme on Substance Use Mortality (NPSUM) and the Preventable Deaths Tracker (PDT) (https ...
Eman Mshari   +2 more
wiley   +1 more source

Patient experience in community pharmacy services: A scoping review. [PDF]

open access: yesJ Gen Fam Med
Kaneko C   +4 more
europepmc   +1 more source

Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?

open access: yes
British Journal of Clinical Pharmacology, EarlyView.
Christina Gao   +3 more
wiley   +1 more source

Community pharmacy resiliency during Covid-19 pandemic in Iran: A qualitative study. [PDF]

open access: yesExplor Res Clin Soc Pharm
Zomorodi Z   +3 more
europepmc   +1 more source

[12th SEFAC Congress: From Transformation to Action in Community Pharmacy].

open access: yesFarm Comunitarios
Díaz Jiménez VJ, Pérez Hoyos E.
europepmc   +1 more source

Home - About - Disclaimer - Privacy